Granules India Ltd
NSE:GRANULES

Watchlist Manager
Granules India Ltd Logo
Granules India Ltd
NSE:GRANULES
Watchlist
Price: 533.9 INR 0.28% Market Closed
Market Cap: 129.4B INR
Have any thoughts about
Granules India Ltd?
Write Note

Granules India Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Granules India Ltd
Operating Income Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Granules India Ltd
NSE:GRANULES
Operating Income
â‚ą7.7B
CAGR 3-Years
2%
CAGR 5-Years
19%
CAGR 10-Years
18%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Income
â‚ą65B
CAGR 3-Years
28%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Operating Income
â‚ą56.2B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
14%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Income
â‚ą112.5B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Income
â‚ą27.8B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
10%
M
Mankind Pharma Ltd
NSE:MANKIND
Operating Income
â‚ą21.5B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Granules India Ltd's Operating Income?
Operating Income
7.7B INR

Based on the financial report for Jun 30, 2024, Granules India Ltd's Operating Income amounts to 7.7B INR.

What is Granules India Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
18%

Over the last year, the Operating Income growth was 18%. The average annual Operating Income growth rates for Granules India Ltd have been 2% over the past three years , 19% over the past five years , and 18% over the past ten years .

Back to Top